A study of the prevalence of significant increases in serum creatinine following angiotension-converting enzyme inhibitor administration


Angiontension-converting enzyme inhibitors (ACEIs) are beneficial in the treatment of diabetic and nondiabetic kidney disease, coronary artery disease and congestive heart failure. One adverse effect of ACEIs use is a rise in serum creatinine and potential renal failure. This paper attempts to quantify this risk and assess the need for pre- and post-ACEI… (More)
DOI: 10.1038/sj.jhh.1001832

4 Figures and Tables


  • Presentations referencing similar topics